ADI’s Repurposing division has worked with leading global pharmaceutical companies on their drug repurposing initiatives, and can accelerate your drug repurposing efforts as well while significantly reducing the costs.
Drug repurposing requires a deep understanding of Structure Activity Relationship, implying building-up substantial amount of data for further sorting and analysis, searching targets, their regulatory pathways, their inter-relationship, recognizing verified targets, finding associated genes and biomarker, identifying repositioning candidate and more.
Team ADI consists of seasoned doctors, experts with significant experience in Bioinformatics and In-silico Drug Design, and professionals from the Pharma industry, also comprising professionals with Wet Lab experience; what is most important is that all of our works show positive results, publications for which are available.
We can proudly say that, during the past 17+ years of our working with the Pharmaceutical Industry, over 80% of this industry, including the top honchos, have used the analytics and reports created at ADI. Our reports, forecasting and clinical trial intelligence data have been consistently rated par excellence and most accurate by industry leaders.